» Articles » PMID: 23536564

The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications

Overview
Journal Cancer Res
Specialty Oncology
Date 2013 Mar 29
PMID 23536564
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

The liver is host to many metastatic cancers, particularly colorectal cancer, for which the last 2 decades have seen major advances in diagnosis and treatment. The liver is a vital organ, and the extent of its involvement with metastatic disease is a major determinant of survival. Metastatic cells arriving in the liver via the bloodstream encounter the microenvironment of the hepatic sinusoid. The interactions of the tumor cells with hepatic sinusoidal and extrasinusoidal cells (endothelial, Kupffer, stellate, and inflammatory cells) determine their fate. The sinusoidal cells can have a dual role, sometimes fatal to the tumor cells but also facilitatory to their survival and growth. Adhesion molecules participate in these interactions and may affect their outcome. Bone marrow-derived cells and chemokines also play a part in the early battle for survival of the metastases. Once the tumor cells have arrested and survived the initial onslaught, tumors can grow within the liver in 3 distinct patterns, reflecting differing host responses, mechanisms of vascularization, and proteolytic activity. This review aims to present current knowledge of the interactions between the host liver cells and the invading metastases that has implications for the clinical course of the disease and the response to treatment.

Citing Articles

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer.

Wang Y, Jia R, Si H, Ma Y, Fan M, Zhang N BMC Cancer. 2025; 25(1):422.

PMID: 40055652 PMC: 11889911. DOI: 10.1186/s12885-025-13794-w.


Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases.

Kuang J, Li J, Zhou S, Li Y, Lin J, Huang W Discov Oncol. 2025; 16(1):241.

PMID: 40009285 PMC: 11865409. DOI: 10.1007/s12672-025-01976-8.


The lncRNA MIR181A1HG in extracellular vesicles derived from highly metastatic colorectal cancer cells promotes liver metastasis by remodeling the extracellular matrix and recruiting myeloid-derived suppressor cells.

Gu Y, Mi Y, Cao Y, Yu K, Zhang Z, Lian P Cell Biosci. 2025; 15(1):23.

PMID: 39972363 PMC: 11841002. DOI: 10.1186/s13578-025-01365-2.


5-hydroxymethylcytosine features of portal venous blood predict metachronous liver metastases of colorectal cancer and reveal phosphodiesterase 4 as a therapeutic target.

Xu N, Gao Z, Wu D, Chen H, Zhang Z, Zhang L Clin Transl Med. 2025; 15(2):e70189.

PMID: 39956959 PMC: 11830572. DOI: 10.1002/ctm2.70189.


Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases.

Beninato T, Amin S, Baine M, Lin C Hepat Oncol. 2025; 11(1):2403323.

PMID: 39881556 PMC: 11444651. DOI: 10.1080/20450923.2024.2403323.